OrthoPediatrics Corp Business Acquisition, Pro Forma Net Income (Loss)
OrthoPediatrics Corp (KIDS) reported Business Acquisition, Pro Forma Net Income (Loss) of -$37.85 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-03-04
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for the quarter ending 2024-12-31 was -$16.14M.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for the quarter ending 2024-09-30 was -$7.90M.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for the quarter ending 2024-06-30 was -$6.03M.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for the quarter ending 2024-03-31 was -$7.79M.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for fiscal 2024 was -$37.85M.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for fiscal 2023 was -$20.51M, a 1072.04% decline from fiscal 2022.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for fiscal 2022 was $2.11M.
- OrthoPediatrics Corp business acquisition, pro forma net income (loss) for fiscal 2021 was -$12.81M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$16.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$24.04M derived: sum of 2 quarters · filed 2026-03-04 | -$30.07M derived: sum of 3 quarters · filed 2026-03-04 | -$37.85M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | -$7.90M 10-Q · filed 2024-11-07 | -$13.93M derived: sum of 2 quarters · filed 2024-11-07 | -$21.71M 10-Q · filed 2024-11-07 | -$28.29M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-06-30 | -$6.03M 10-Q · filed 2024-08-06 | -$13.81M 10-Q · filed 2024-08-06 | -$20.39M derived: sum of 3 quarters · filed 2026-03-04 | -$24.86M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-03-31 | -$7.79M 10-Q · filed 2024-05-07 | -$14.36M derived: sum of 2 quarters · filed 2026-03-04 | -$18.84M derived: sum of 3 quarters · filed 2026-03-04 | -$21.61M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2023-12-31 | -$6.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$11.05M derived: sum of 2 quarters · filed 2026-03-04 | -$13.82M derived: sum of 3 quarters · filed 2026-03-04 | -$20.51M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | -$4.47M 10-Q · filed 2024-11-07 | -$4.59M 10-Q · filed 2023-11-07 | -$7.25M derived: sum of 2 quarters · filed 2024-11-07 | -$13.94M 10-Q · filed 2024-11-07 | -$14.28M 10-Q · filed 2023-11-07 | -$21.84M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$2.77M 10-Q · filed 2024-08-06 | -$2.89M 10-Q · filed 2023-08-01 | -$9.46M 10-Q · filed 2024-08-06 | -$9.69M 10-Q · filed 2023-08-01 | -$17.36M derived: sum of 3 quarters · filed 2024-08-06 | $1.18M derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | -$6.69M 10-Q · filed 2024-05-07 | -$6.81M 10-Q · filed 2023-05-02 | -$14.59M derived: sum of 2 quarters · filed 2024-05-07 | $3.95M derived: sum of 3 quarters · filed 2024-05-07 | $3.83M derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $10.64M derived: sum of 2 quarters · filed 2024-03-08 | $10.52M derived: sum of 3 quarters · filed 2024-03-08 | $2.11M 10-K · filed 2024-03-08 | |||
| 2022-09-30 | $18.54M 10-Q · filed 2023-11-07 | $18.43M derived: sum of 2 quarters · filed 2023-11-07 | $10.01M 10-Q · filed 2023-11-07 | $10.21M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-06-30 | -$112.00K 10-Q · filed 2023-08-01 | -$9.10M 10-Q · filed 2023-08-01 | -$8.33M derived: sum of 3 quarters · filed 2024-03-08 | -$10.19M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-03-31 | -$8.99M 10-Q · filed 2023-05-02 | -$8.22M derived: sum of 2 quarters · filed 2024-03-08 | -$10.08M derived: sum of 3 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$1.09M derived: sum of 2 quarters · filed 2024-03-08 | -$12.81M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | -$1.86M 10-Q · filed 2022-11-01 | -$13.58M 10-Q · filed 2022-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |